{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-034182","form_type":"8-K","ticker":"FBLG","cik":"0001958777","company_name":"FibroBiologics, Inc.","filed_at":"2024-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.272816+00:00","generated_at":"2026-05-31T07:16:58.331757+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"FibroBiologics' shareholders approve capital stock decrease, elect directors","bullets":["Shareholders elected Richard Cilento and Robert Hoffman as Class I directors for terms expiring 2027; both received over 47M votes for.","Capital Decrease Amendment to reduce authorized capital stock approved with ~48.2M for, 11K against; filed Aug 27.","Clarifying Amendment to eliminate obsolete provisions approved; Amended and Restated Certificate of Incorporation effective Aug 27.","WithumSmith+Brown ratified as independent auditor for FY2024 with 54.95M for votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-034182","json":"https://secwatch.observer/filing/0001493152-24-034182.json","markdown":"https://secwatch.observer/filing/0001493152-24-034182.md","text":"https://secwatch.observer/filing/0001493152-24-034182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958777/000149315224034182/0001493152-24-034182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958777/000149315224034182/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:16:58.331757+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}